Kobayashi Pharmaceutical Co (TSE:4967) Total Liabilities : 円56,286 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co Total Liabilities?

Kobayashi Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 was 円56,286 Mil.

Kobayashi Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2023 (円56,326.00 Mil) to Dec. 2023 (円62,657.00 Mil) but then declined from Dec. 2023 (円62,657.00 Mil) to Mar. 2024 (円56,286.00 Mil).

Kobayashi Pharmaceutical Co's annual Total Liabilities increased from Dec. 2021 (円56,955.00 Mil) to Dec. 2022 (円57,928.00 Mil) and increased from Dec. 2022 (円57,928.00 Mil) to Dec. 2023 (円62,657.00 Mil).

Kobayashi Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Total Liabilities Chart

Kobayashi Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

61,075.00

55,784.00

56,955.00

57,928.00

62,657.00

Kobayashi Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															54,095.00	57,983.00	56,326.00	62,657.00	56,286.00

Kobayashi Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kobayashi Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	56111	+	(608	+	4999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	939)
	=	62,657

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	267473	-	204816
	=	62,657

Kobayashi Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	50952	+	(577	+	3785
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	972)
	=	56,286

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	261253	-	204967
	=	56,286

Kobayashi Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kobayashi Pharmaceutical Co (TSE:4967) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

KOY:Germany

Address

KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.kobayashi.co.jp

Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (TSE:4967) Headlines

No Headlines